Beo Therapeutics
PrivateLast Round
Grant
Aug 28, 2024
Total Funding Raised
$4.19M
Company Overview
Beo Therapeutics operates in Healthcare & Life Sciences and is based in Hjørring. Its latest recorded funding round was a Grant round in August 2024.
Beo Therapeutics is a biotechnology company that develops oral microbiome therapies to counteract diseases caused by metabolic waste products, such as gouty arthritis and chronic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beo Therapeutics Comparables
Compare Beo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caelus Health | 78% | |
| Genbioma Aplicaciones | 77% | |
| MRM Health | 77% |
For institutional investors. Book with your work email.
Beo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 28, 2024 | ||||
| Angel | Jul 1, 2019 |
For institutional investors. Book with your work email.
Beo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Business Angels Switzerland | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors grew 124% MoM, reaching 1.6K.
- Mar 7, 2025
Monthly visitors grew 34% MoM.
For institutional investors. Book with your work email.
Beo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beo Therapeutics's valuation, stock price, and market status.
Is Beo Therapeutics a public or private company?
Beo Therapeutics is a private company.
What is the current stock price of Beo Therapeutics?
Beo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Beo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beo Therapeutics worth (valuation)?
Valuation information for Beo Therapeutics is not publicly available.
Can I buy Beo Therapeutics stock?
Beo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beo Therapeutics's last funding round?
Beo Therapeutics's most recent funding round was Grant on August 28, 2024.
Who are the main investors in Beo Therapeutics?
Key investors in Beo Therapeutics include European Innovation Council, Business Angels Switzerland.
Will Beo Therapeutics IPO soon?
No public IPO plans have been announced for Beo Therapeutics.
How can I track Beo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Beo Therapeutics's shares on secondary markets.